Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, Bloomberg, CNBC, Discovery, RT, Viacom, and WIRED, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Aon, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.
WHY THIS MATTERS IN BRIEF
Why raise chickens for meat when you can just grow that meat in a lab without all the anti-biotics, environmental damage, and nuisance?
Love the Exponential Future? Join our XPotential Community, future proof yourself with courses from XPotential University, read about exponential tech and trends, connect, watch a keynote, or browse my blog.
A few years ago if you wanted to buy a chicken nugget, or a burger, then that meat would have come from an animal, but now thanks to Cellular Agriculture, which uses an advanced manufacturing technology called a bio-reactor to grow meat without the animal, you don’t need the animal any longer. And while you couldn’t buy meat cultivated in this way in the US you could in Singapore after the government passed regulations to allow its sale a couple of years ago. Now though, if you live in the US you can buy it soon too after the FDA gave it the thumbs up.
In 2020, cultured meat startup Memphis Meats raised $161 million in Series B funding, making it the most-funded startup in the industry. The investment validated cultured meat’s technological soundness and indicated that consumer interest in these products was likely to grow.
After changing its name to Upside Foods in 2021, the company received an additional $400 million in Series C funding this past April. Now they’ve reached another milestone: this week the FDA granted the company the first approval needed to bring its meat to consumers.
Learn more about feeing 8 Billion people, by keynote Matthew Griffin
The approval is called a No Questions letter and means that after conducting a thorough evaluation the FDA concluded that Upside’s lab made poultry is safe to eat. The letter doesn’t apply to all of the company’s products, only to its cultured chicken for now; additional offerings will have to undergo the same FDA evaluation process.
“This milestone marks a major step towards a new era in meat production, and I’m thrilled that US consumers will soon have the chance to eat delicious meat that’s grown directly from animal cells,” said Dr. Uma Valeti, Upside’s CEO and founder.
The No Questions letter isn’t an easy approval to lock down, and now that Upside has it, the remaining steps to start selling its chicken should move relatively quickly. The company’s production facilities and the chicken itself will both need to pass USDA inspections and receive seals of approval.
A year ago Upside opened its EPIC facility, a 53,000-square-foot center for engineering, production, and innovation in Emeryville, California. Not all of the space is operational yet, but the facility will eventually be able to produce multiple types of lab made meat, poultry, and seafood; Upside plans to initially make more than 50,000 pounds of meat per year there, scaling up to more than 400,000 pounds per year.
Once the company receives the remaining two approvals it needs, its cultured chicken won’t be available in grocery stores right away; curious consumers will first be able to try it in select restaurants.
“We would want to bring this to people through chefs in the initial stage,” Valeti said. “We want to work with the best partners who know how to cook well, and also give us feedback on what we could do better.” The first to sign on is Dominique Crenn, a Michelin-starred chef who runs Atelier Crenn restaurant in San Francisco.
Cultured meat is made by harvesting muscle cells from an animal then feeding those cells a mixture of nutrients and growth factors so that they multiply, differentiate, then grow to form muscle tissue; it’s not terribly different from the way muscle grows in vivo. But the bio-reactors where growth happens don’t produce ready-to-eat cuts of meat. The harvested cells need to be refined and shaped into a final product, which could involve extrusion cooking, molding, and even 3D printing.
This process isn’t cheap, especially because it’s still in its very early years and hasn’t yet been scaled to any significant level. Upside doesn’t share details of its production costs, but it seems the per-unit cost of cultured meat is generally trending downward: last year the cost of lab-grown chicken reached $7.70 per pound, as compared to an average at the time of $3.62 per pound for conventional chicken.
Valeti plans to focus on scaling production over the next few years. He’s not alone; competitor Good Meat is planning to build a large cultured meat production facility in the US, aiming for domestic production to start by late 2024.
Besides lowering costs, raising consumer awareness about the benefits of cultured meat products will also be key; namely, that they’re better for animals and for the environment but offer an identical nutritional profile to farmed meat.
Valeti seems optimistic. “Our goal is to introduce consumers to cultivated meat to dispel any confusion with meat alternatives,” he said. “This is going to open up the entire cultivated meat space, and as the pioneer, we are writing the playbook and sharing it with people… the consumer will fall in love with this.”